Compare T-Rex 2X Long MSTR Daily Target ETF (MSTU) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
T-Rex 2X Long MSTR Daily Target ETF vs Smith & Nephew plc — how do they compare? T-Rex 2X Long MSTR Daily Target ETF trades at $30.68, while Smith & Nephew plc trades at $27.96 (market cap $11.62B). The key difference: Smith & Nephew plc pays a 2.86% dividend while T-Rex 2X Long MSTR Daily Target ETF pays none. Which is the better fit depends on your goals.
| MSTU | SNN | |
|---|---|---|
Sector | Leveraged / Inverse | Health |
52-Week High | $573.00 | $38.53 |
52-Week Low | $14.60 | $27.80 |
Market Cap | — | $11.62B |
Enterprise Value | — | $14.66B |
Dividend Yield | — | 2.86% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MSTU trades at $33.31, down 8.64% today, with technical indicators showing a bullish trend supported by moving averages. The ETF recently underwent a 10:1 reverse stock split and declared a $0.29 dividend payable in August 2026. Recent news highlights significant trading activity as investors seek leveraged exposure to MicroStrategy amid Bitcoin volatility, though the fund has experienced substantial value erosion over the past year.
The outlook remains volatile given MSTU's leveraged structure, which compounds daily moves. While technical momentum appears positive, fundamental risks include the amplified exposure to MicroStrategy's performance and crypto market swings. Investors should weigh the potential for rapid gains against the documented risk of significant value erosion in leveraged products.
SNN trades at $27.87, down 3.46% today and near a 52-week low. Technical indicators are bearish, but oversold RSI levels suggest potential for a rebound. Fundamentally, the company shows strong revenue growth to $6.16 billion in 2025 and a net income margin of 10.08%, though recent guidance cuts and CFO departure have weighed on sentiment. A dividend of $0.31 is scheduled for payment in November 2026.
The outlook is cautious due to competitive pressures and execution risks, but valuation metrics like a P/E of 18.96 appear reasonable. Analyst consensus is Hold, with 65% recommending neutrality. Upside depends on improved operational performance and stabilization in key markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About T-Rex 2X Long MSTR Daily Target ETF
MSTU is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bullish (long) position in MSTR, a company known for its significant Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on MSTU →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
